Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
Organizers of a planned Islamic center near Ground Zero say they want to repair the breach caused by the nine-eleven terrorist attacks. Opponents consider the location insensitive. Leaders of different religions discuss attitudes toward Islam in America.
- Barry Lynn executive director of Americans United for Separation of Church and State and author of "Piety & Politics" (Harmony Books)
- Akbar Ahmed chair of Islamic studies at American University, the first Distinguished Chair of Middle East and Islamic Studies at the U.S. Naval Academy, and former Pakistani high commissioner to the U.K. His latest book is "Journey into America."
- The Rt. Rev. John Chane Bishop of the Episcopal Diocese of Washington
- Rabbi Bruce Lustig Senior Rabbi of the Washington Hebrew Congregation
- Dan Senor Former Bush Administration foreign policy advisor, based in Iraq (2003, 2004) Currently founding partner of Rosemont Capital, a global private equity firm; and Fox News Middle East Analyst
Most Recent Shows
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.
Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.
The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.